DataLabs Announces Industry's First Middleware Product Built Specifically for the Biopharmaceutical Industry
New integration platform leverages a library of predefined connectors and allows clients to write their own custom connectors, easing the pain of creating and managing system integrations.
IRVINE, Calif.-June 14, 2006-DataLabs, an innovative developer of Internet-based software applications for clinical development, today announced the release of DataLabs Connect™ v2.0. DataLabs Connect is an enterprise-level middleware product built specifically for the biopharmaceutical industry. A first for the industry, DataLabs Connect includes an application server, management portal, connector framework and predefined connectors that integrate the entire suite of DataLabs' products including Galt Associates dsNavigator encoding and dictionary management product and other best-of-breed products.
DataLabs will be at booth #1829 at the DIA Annual Conference
Articles in this issue
about 19 years ago
Article
Phase Forward Delivers Enhanced Integration Capabilities as Part of Ongoing Adapter Strategyabout 19 years ago
Article
ClinPhone Exhibits its Clinical Trial Technology Solutions at 42nd DIA Annual Meetingabout 19 years ago
Article
Omnicomm Systems Inc., Introduces New TrialMaster V.4.0 at DIA's 42nd Annual MeetingNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMGSeptember 15th 2025
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
